![]() | 姓 名: | 郑小虎 |
地 址: | 中国科学技术大学生命科学学院 | |
邮 编: | 230027 | |
电 话: | 0551-63600637 | |
电 邮: | ustczxh@ustc.edu.cn | |
主 页: | http://ioi.ustc.edu.cn |
教育与科研经历 |
2009/09-2015/05 | 中国科学技术大学生命科学学院,获博士学位 |
2015/06-2017/05 | 中国科学技术大学生命科学学院,博士后 |
2017/06-2018/4 | 中国科学技术大学生命科学学院,特任副研究员 |
2018/05-2021/10 | 中国科学技术大学生命科学学院,副研究员 |
2021/11-至今 | 中国科学技术大学生命科学学院,特任教授 |
目前研究方向 |
1. | 肿瘤抗体药物研发 |
2. | 肿瘤免疫逃逸 |
代表性论文 |
1. | Xiaohu Zheng, Yeben Qian, Binqing Fu, Defeng Jiao, Yong Jiang, Peng Chen, Yiqing Shen, Huafeng Zhang, Rui Sun, Zhigang Tian* and Haiming Wei *, Mitochondrial fragmentation limits natural killer cell-based tumour immunosurveillance Nature immunology, Accepted, Sep 2019. |
2. | Xiaohu Zheng , Fan X, Fu B, Zheng M, Zhang A, Zhong K, Yan J, Sun R, Tian Z*, Wei H*, EpCAM inhibition sensitizes chemoresistant leukemia to immune surveillance. Cancer Research, JAN 15 2017, 77; 482-493. |
3. | Xiaohu Zheng, Min Cheng, Binqing Fu, Xiaolei Fan, Qing Wang, Xiaoqing Yu, Rui Sun, Zhigang Tian*, Haiming Wei*. Targeting LunX inhibits non-small-cell lung cancer growth and metastasis. Cancer Research, March 15, 2015 75; 1080-90. |
4. | Xiaohu Zheng, Zhigang Tian, Haiming Wei*. Lung specific X protein as a novel therapeutic target for lung cancer. OncoImmunology, 2015 Aug 17;4(12):e1052931. |
5. | Yong Jiang#, Xiaohu Zheng#, Defeng Jiao, Peng Chen, Yechuan Xu, Haiming Wei*, Yeben Qian*. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma. EBioMedicine, 2019 Feb;40:422-431. |